All Perspectives

A lawsuit against sneaker brand On asks how much national pride a label can sell before it crosses the line into deception.

Health Care Practice Co-Leader Douglas Grimm was a featured guest on Competition Policy International, a PYMNTS company, to discuss how deregulating artificial intelligence (AI) for use in health care doesn’t necessarily remove barriers to the industry’s adoption.

Longevity & Healthspan Industry Co-Leader Abha Kundi, a former US Food and Drug Association (FDA) regulatory counsel, was quoted on a recent vote from an FDA advisory committee that recommended six (out of seven) peptide substances for lawful compounding.

Counsel Judah Prero was quoted on the Minnesota Chamber of Commerce’s request to state regulators to delay reporting requirements for products containing per- and polyfluoroalkyl substances (PFAS).

ArentFox Schiff announced today the addition of an elite trademark and brands team anchored by highly ranked brand and copyright attorney Jason Garcia and globally recognized trademark attorney Katherine (Katy) M. Basile.

On June 17, the Council of the European Union (EU) and the European Parliament formally adopted the long-debated regulation for plants developed using certain new genomic techniques (NGTs).

Can your association board and senior leadership team answer these seemingly straightforward questions: “Where are our most important contracts, and is someone tracking what they require?” For many associations, the honest answer is that contract management happens in pieces across departments, in response to questions, and without dedicated trade association legal counsel weighing in until a problem surfaces.

Family Offices Industry Co-Leader Kevin Matz was quoted on the value of trust protectors in both revocable and irrevocable trust plans and can be useful even for responsible family members.

Earlier this year we flagged New York’s “synthetic performer” disclosure law, N.Y. General Business Law § 396-b, the Synthetic Performer Law, as one to watch. The watch is over.

On July 14, the US Food and Drug Administration (FDA) announced final guidance regarding clinical investigations of psychedelic drugs.

Prop 65 Counsel: What To Know

Headlines that Matter for Companies and Executives in Regulated Industries

A recent California Superior Court decision against Kars4Kids, the charity known for its memorable advertising jingle, demonstrates the significant risks that charities can face if their solicitations are found to be misleading.

The Pharmacy Compounding Advisory Committee (PCAC) is a 14-member US Food and Drug Administration (FDA) advisory panel of pharmacists, physicians, and other experts. It reviews the scientific and safety record for bulk drug substances nominated for compounding and votes on non-binding recommendations to the FDA.

The US Department of Justice (DOJ) is increasingly using the False Claims Act (FCA) to pursue customs fraud, tariff evasion, and duty underpayments, resulting in significant settlements and expanded enforcement activity.

On June 26, Illinois Governor JB Pritzker signed House Bill 4517 into law, amending the Illinois Authorized Electronic Monitoring in Long-Term Care Facilities Act.

On July 13, the US Food and Drug Administration (FDA) proposed a new rule that would fundamentally change how certain drug manufacturers register their facilities and list their products with the agency.

California family offices with clients at or near the $1 billion net worth threshold should be monitoring Proposition 40, the 2026 Billionaire Tax Act, which has qualified for the November 3 ballot and could impose a one-time tax of up to 5% on the net worth of certain California residents if approved by voters.

ArentFox Schiff Partners Kevin Matz, Brian Janowsky, and Tracy McLaughlin will present “Qualified Opportunity Zones and Estate Planning After OBBBA” during a Strafford webinar on July 30, 2026.

In Wilbur-Ellis Company v. Gompert, the US Court of Appeals for the Eighth Circuit affirmed summary judgment for defendants, four former employees of plaintiff, who brought claims against them under the Defend Trade Secrets Act (DTSA) and the Nebraska Trade Secrets Act (NTSA). The Eighth Circuit affirmed the district court’s decision holding that the plaintiff employer had failed to identify its alleged secrets with specificity and had failed to connect circumstantial evidence to any particular trade secret or improper use.

AFS Partner and Family Office Co-Chair Kevin Matz analyzes the IRS’s newly issued transfer tax safe harbor for contributions to Trump accounts and examines its implications for gift and generation-skipping transfer tax reporting in a recent article for TaxStringer.

Welcome to the July 2026 issue of “As the (Customs and Trade) World Turns,” our monthly newsletter where we compile essential updates from the customs and trade world over the past month. We bring you the most recent and significant insights in an accessible format, concluding with our main takeaways — aka “And the Fox Says…” — on what you need to know.

The US data center sector is in the midst of a historic capital cycle as artificial intelligence (AI), cloud computing, and digital infrastructure demand pushes hyperscalers and colocation providers to commit capital at unprecedented scale.

On July 2, the Centers for Medicare & Medicaid Services (CMS) released the Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P).

On July 7, US Securities and Exchange Commission (SEC) Chairman Paul S. Atkins issued a statement outlining the agency’s 2026 Regulatory Agenda and its key priorities for the coming year.